These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 19087840

  • 1. [Methodology and clinical impact of studies of mortality in chronic obstructive pulmonary disease].
    Soler-Cataluña JJ, Martínez García MA.
    Arch Bronconeumol; 2008; 44 Suppl 2():21-8. PubMed ID: 19087840
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Methodology and clinical impact of studies on disease progression].
    García Río F.
    Arch Bronconeumol; 2008; 44 Suppl 2():29-38. PubMed ID: 19087841
    [Abstract] [Full Text] [Related]

  • 4. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
    Lee TA, Schumock GT, Bartle B, Pickard AS.
    Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Managing stable COPD in 2009: incorporating results from recent clinical studies into a goal-directed approach for clinicians.
    Rubins JB, Raci E, Kunisaki KM.
    Postgrad Med; 2009 Jan; 121(1):104-12. PubMed ID: 19179818
    [Abstract] [Full Text] [Related]

  • 9. [Chronic obstructive pulmonary disease: brief review].
    Fabbri LM, Romagnoli M, Cossi S, Grassi V.
    Ann Ital Med Int; 2003 Jan; 18(4):219-30. PubMed ID: 14971710
    [Abstract] [Full Text] [Related]

  • 10. Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease.
    Sin DD, Man SF.
    Curr Opin Pulm Med; 2008 Mar; 14(2):115-21. PubMed ID: 18303420
    [Abstract] [Full Text] [Related]

  • 11. Potential role of leukotriene modifiers in the treatment of chronic obstructive pulmonary disease.
    Usery JB, Self TH, Muthiah MP, Finch CK.
    Pharmacotherapy; 2008 Sep; 28(9):1183-7. PubMed ID: 18752388
    [Abstract] [Full Text] [Related]

  • 12. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease.
    Molinos L, Clemente MG, Miranda B, Alvarez C, del Busto B, Cocina BR, Alvarez F, Gorostidi J, Orejas C, ASTURPAR Group.
    J Infect; 2009 Jun; 58(6):417-24. PubMed ID: 19329187
    [Abstract] [Full Text] [Related]

  • 13. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A, Gürgün C.
    Tuberk Toraks; 2008 Jun; 56(4):464-71. PubMed ID: 19123087
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Coded cause of death and timing of COPD diagnosis.
    Pickard AS, Jung E, Bartle B, Weiss KB, Lee TA.
    COPD; 2009 Feb; 6(1):41-7. PubMed ID: 19229707
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.